Henlius Has Denosumab Application Accepted In China

NMPA Also Currently Reviewing Adalimumab And Trastuzumab Filings

 
• By Akriti Seth
  
Compass_Yes
Henlius has had its denosumab filing accepted by China’s NMPA • Source: Shutterstock

More from Biosimilars

More from Products